Mark Foletta – Biography
Last update: 20 days agoExecutive profile
Mark was Chief Financial Officer at Biocept, and Senior Vice President of Finance and Chief Financial Officer at Amylin Pharmaceuticals.
Mark Foletta is currentlyDirector at Enanta Pharmaceuticals - View - Enanta Pharmaceuticals org chart
Interim Chairman of the Board at DexCom - View - DexCom org chart
Create your alert
to follow the career of Mark Foletta.
Education
In 1982, Mark Foletta completed a Bachelor of Arts in Business Economics at University of California, Santa Barbara.
They have also studied at University of California, Santa Barbara :
Find more alumni from University of California, Santa Barbara
More about Mark Foletta
Selected links
Do you need to know more about Mark Foletta? More results.
Participate
Social media
- Mark Foletta on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mark Foletta
The colleagues of Mark Foletta
Company Colleagues
- At Enanta Pharmaceuticals, Mark Foletta has 27 colleagues including Jay Luly (CEO & Director), Kristine Peterson (Director)…
- At DexCom, Mark Foletta has 46 colleagues including Jacob Leach (CEO), Bridgette Heller (Director)…
Homonyms
- Mark Foletta - Chairman of the Board - AMN Healthcare
Industry Colleagues
- In the Medical Equipment industry, Mark Foletta has 15,333 colleagues in 1,246 companies located in 46 countries. 8,581 executive movements have been recorded in the last 12 months. Learn more about Medical Equipment.
Report an error
Update the org chart details of Mark Foletta.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Mark Foletta.
